home / stock / atra / atra quote
Last: | $7.52 |
---|---|
Change Percent: | 0.24% |
Open: | $8.34 |
Close: | $7.52 |
High: | $8.34 |
Low: | $7.3101 |
Volume: | 93,158 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.52 | $8.34 | $7.52 | $8.34 | $7.3101 | 93,158 | 07-02-2024 |
$8.36 | $8.5 | $8.36 | $8.8 | $8.21 | 156,123 | 07-01-2024 |
$8.5 | $8.17 | $8.5 | $9.0999 | $8.17 | 746,152 | 06-28-2024 |
$8.26 | $7.3 | $8.26 | $8.39 | $7.07 | 147,484 | 06-27-2024 |
$7.295 | $7.78 | $7.295 | $7.84 | $7.27 | 75,835 | 06-26-2024 |
$7.78 | $8.29 | $7.78 | $8.4 | $7.425 | 133,681 | 06-25-2024 |
$8.285 | $8.29 | $8.285 | $8.4684 | $7.71 | 122,303 | 06-24-2024 |
$8.23 | $8.91 | $8.23 | $9 | $7.41 | 439,055 | 06-21-2024 |
$8.9 | $9.59 | $8.9 | $10 | $8.77 | 102,164 | 06-20-2024 |
$0.3946 | $0.4116 | $0.3946 | $0.4156 | $0.3724 | 2,595,817 | 06-19-2024 |
$0.3946 | $0.4116 | $0.3946 | $0.4156 | $0.3724 | 2,595,817 | 06-18-2024 |
$0.4245 | $0.445 | $0.4245 | $0.4537 | $0.3915 | 4,756,618 | 06-17-2024 |
$0.511 | $0.5072 | $0.511 | $0.55 | $0.4967 | 1,280,210 | 06-14-2024 |
$0.5275 | $0.5344 | $0.5275 | $0.54 | $0.5125 | 562,584 | 06-13-2024 |
$0.5449 | $0.567 | $0.5449 | $0.5866 | $0.5345 | 454,505 | 06-12-2024 |
$0.5621 | $0.5018 | $0.5621 | $0.5621 | $0.5018 | 656,863 | 06-11-2024 |
$0.522 | $0.54 | $0.522 | $0.5499 | $0.49 | 1,203,628 | 06-10-2024 |
$0.5288 | $0.57 | $0.5288 | $0.57 | $0.52 | 1,321,147 | 06-07-2024 |
$0.5691 | $0.59 | $0.5691 | $0.59 | $0.5526 | 1,120,764 | 06-06-2024 |
$0.579 | $0.5668 | $0.579 | $0.5871 | $0.55 | 920,930 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Atara Biotherapeutics Inc. Company Name:
ATRA Stock Symbol:
NASDAQ Market:
Atara Biotherapeutics Inc. Website:
2024-06-27 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ebvallo is the First and Only Approved Therapy in Europe for Adults and Children with EBV+ PTLD Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies ...
2024-06-20 09:02:05 ET Atara Biotherapeutics Inc (ATRA) announced stock split at a ratio of 1-for-25 on 2024-06-20 ... Full story available on KlickAnalytics.com